RYTMRHYTHM PHARMACEUTICALS INC
CUSIP 76243J105 · common stock
8 tracked investors held RHYTHM PHARMACEUTICALS INC (RYTM) at the end of Q3 2026, worth $1.8B in total. The largest holder was RA Capital Management, with 6.4% of its portfolio. Ken Fisher opened a new position this quarter.
Holders · Q3 2026
8
New holders
1
Value held
$1.8B
Quarter-end price (est.)
$95.22
Investors holding RYTM · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 6.37% | 6,666,837 | $634.8M | HOLD |
| Julian Baker Baker Bros. Advisors LP | 2.54% | 5,604,483 | $533.6M | HOLD |
| PRIMECAP Management PRIMECAP Management Co | 0.18% | 3,064,317 | $291.8M | REDUCE-3.3% |
| Perceptive Advisors Perceptive Advisors LLC | 4.20% | 2,532,556 | $241.1M | REDUCE-2.1% |
| Stanley Druckenmiller Duquesne Family Office LLC | 0.57% | 269,900 | $25.7M | ADD+32.6% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.56% | 138,658 | $13.2M | ADD+1.8% |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 105,999 | $10.1M | NEW |
| Joel Greenblatt Gotham Asset Management, LLC | 0.00% | 5,107 | $486.3K | REDUCE-7.4% |